Cash & equivalents increased 131.2%
Cash & equivalents changed +131.2% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +131.2% from the comparable as-filed period.
Gross margin changed +162 basis points from the comparable as-filed period.
Gross profit changed +100.7% from the comparable as-filed period.
Inventory changed +98.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +70.7% from the comparable as-filed period.
Operating income changed +130.7% from the comparable as-filed period.
Operating margin changed +169 basis points from the comparable as-filed period.
Revenue changed +69.7% from the comparable as-filed period.
Selling, general & administrative changed +57.2% from the comparable as-filed period.
Research & development changed +2.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.